Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)

NCT00781846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: ridaforolimus
DRUG: bevacizumab

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]